Filtros de búsqueda

Lista de obras de Rachel Jones

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

artículo científico publicado en 2009

A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis

artículo científico publicado en 2019

Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis.

artículo científico publicado en 2016

B cell therapy in ANCA-associated vasculitis: current and emerging treatment options

scientific article published on 14 August 2018

Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial

artículo científico publicado en 2018

Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy

scientific article published on 01 April 2020

Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis.

artículo científico publicado en 2019

Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa

artículo científico publicado en 2015

Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis

scientific article published on 01 August 2019

Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case series

artículo científico publicado en 2015

Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment

scientific article published on 01 September 2006

Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis

artículo científico publicado en 2014

Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

scientific article published on 03 December 2008

Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial

scientific article published on 05 January 2019

Progress in treatment of ANCA-associated vasculitis

artículo científico publicado en 2012

Pulmonary Involvement in Antineutrophil Cytoplasmic Antibodies (ANCA)-associated Vasculitis: The Influence of ANCA Subtype.

artículo científico publicado en 2017

Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease

artículo científico publicado en 2014

Respiratory syncytial virus pneumonitis complicating immunosuppressive treatment for ANCA-positive vasculitis.

artículo científico publicado en 2003

Response to: 'MYCYC, unravelling the long road ahead in ANCA-associated vasculitis' by Jain et al

scientific article published on 20 March 2019

Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients

scientific article published on 30 August 2019

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

scientific article published on 24 June 2020

Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.

artículo científico publicado en 2012

Rituximab in the treatment of anti-neutrophil cytoplasm antibody-associated vasculitis

scientific article published on 14 November 2014

Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production

scientific article published on 20 May 2008

Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial.

artículo científico publicado en 2017

Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease.

artículo científico publicado en 2014

The Longitudinal Course of Fatigue in Antineutrophil Cytoplasmic Antibody-associated Vasculitis

artículo científico publicado en 2019

Treatment of Relapses in ANCA-Associated Vasculitis

artículo científico publicado en 2019

Treatment of primary systemic vasculitis with the inosine monophosphate dehydrogenase inhibitor mycophenolic acid

artículo científico publicado en 2010

Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis

artículo científico publicado en 2018

Tubular Lesions Predict Renal Outcome in Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis after Rituximab Therapy ⬇️

artículo científico publicado el 17 de noviembre de 2011

Update on Lupus Nephritis for GPs

scientific article published on 01 October 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda